Assessment of Lung Transplant Recipients Within The Scope of International

Status Completed

Clinical Trial Summary

This study was aimed to evaluate the patients undergoing lung transplantation under the International Classification of Functionality, Disability and Health (ICF) and to examine the relationships between the age at which lung transplant recipients were transplanted and recipients' comorbidity levels and body structure and functions, activity and participation level.

Clinical Trial Description

After lung transplantation, many complications related to various reasons are observed in patients in the long term. In this study, the severity of fatigue, limitation of daily living activities, kinesophobia, impaired sleep quality, anxiety and depression level, fragility level, balance and functional capacity in lung transplant recipients; investigators aimed to examine the relationship between the age at which the patient was transplanted and the level of comorbidity. Although there are studies on comorbidities, quality of life, daily living activities and participation level, anxiety and depression level, sleep quality, balance and physical fitness level in lung transplant recipients, kinesiophobia upper extremity functional performance in patients who have undergone lung transplantation surgery, COVID-19 infection There are no studies evaluating the anxiety associated with the disease. No study evaluating body structure functions, activity and participation level based on ICF in lung transplantation has been encountered. In our study, patients with at least 3 months past lung transplantation and without orthopedic and mental problems will be evaluated. It will be made as a single evaluation. The last pulmonary function test results of the patients, comorbidity conditions, fatigue, respiratory quality of life, coronavirus anxiety status, sleep quality, kinesophobia will be evaluated by questionnaires. Lower extremity dynamic balance and mobility will be evaluated with 1 minute sit-to-stand test, timed up and go test. Upper extremity functionality will be evaluated with a 6-minute pegboard and ring test. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT05376605
Study type	Observational
Source	Ankara City Hospital Bilkent
Contact
Status	Completed
Phase
Start date	January 27, 2021
Completion date	November 11, 2021

View Details

See also
Status	Clinical Trial	Phase
Recruiting	`NCT05526950` - Cytokine Filtration in Lung Transplantation: A Swedish National Study (GLUSorb)	N/A
Recruiting	`NCT05916495` - An Evaluation of Remote Care (Questionnaire+Hybrid) in Patients Who Are Post-lung Transplant	N/A
Enrolling by invitation	`NCT05950724` - RENAL: TNF-alpha Inhibitor for Improving Renal Dysfunction and Primary Graft Dysfunction After Lung Transplant	Early Phase 1
Active, not recruiting	`NCT05505422` - Routine Versus Selective Intraoperative ECMO in Lung Transplant	N/A
Recruiting	`NCT05081141` - HHV8 and Solid Organ Transplantation
Enrolling by invitation	`NCT04522388` - Examining the Effect of Nutritional Supplementation on Skeletal Muscle Mass in Patients Awaiting Lung Transplant	N/A
Completed	`NCT04165161` - Performance Diagnosis of a Patent Foramen Ovale During Lung Transplantation Using Transesophageal Echocardiography	N/A
Recruiting	`NCT05050955` - AlloSure Lung Assessment and Metagenomics Outcomes Study
Withdrawn	`NCT03258801` - Pirfenidone as Bridging Therapy for Lung Transplant in Patients Suffering From Idiopathic Pulmonary Fibrosis
Completed	`NCT04892719` - 4DX Functional Lung Imaging in the Diagnosis of Chronic Lung Allograft Dysfunction After Lung Transplantation	N/A
Completed	`NCT03221764` - Intraoperative Amiodarone to Prevent Atrial Fibrillation in Lung Transplant Patients	Phase 2
Active, not recruiting	`NCT04975607` - Live Music Therapy to Reduce Anxiety, Pain and Improve Sleep in Post-Operative Lung Transplant Patients: A Pilot Study	N/A
Completed	`NCT05116748` - COVID19 Vaccine in SOT Adult Recipients
Recruiting	`NCT03367221` - Physiological Response in Lung Transplant Recipients Undergoing Neurally Adjusted Ventilatory Assist	N/A
Recruiting	`NCT03276403` - Primary Graft Dysfunction Score in Lung Transplantation	N/A
Active, not recruiting	`NCT03656926` - Efficacy + Safety of Liposome Cyclosporine A to Treat Bronchiolitis Obliterans Post Single Lung Transplant (BOSTON-2)	Phase 3
Completed	`NCT05242289` - Cytokine Adsorption in Lung Transplantation	N/A
Recruiting	`NCT04837339` - Diagnostic and Prognostic Biomarkers of Transplant Dysfunction in the Context of Lung Transplantation	N/A
Not yet recruiting	`NCT04377139` - Management of Cytomegalovirus (CMV) Infection in Lung Transplant Recipients (LTR)
Not yet recruiting	`NCT06399302` - Prospective Multicenter Research on Donor and Recipient Management Strategies to Improve Lung Transplant Outcomes

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

Assessment of Lung Transplant Recipients Within The Scope of International Classification of Functioning, Disability and Health

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms